Skip to content
Home/Companies/Healthcare/PHAXIAM THERAPEUTICS

PHAXIAM THERAPEUTICS

Healthcare·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns PHAXIAM THERAPEUTICS?

PHAXIAM THERAPEUTICS is currently owned by Go Capital through GOCA3 (2023 vintage), since 2023.

Hand-verified · updated 2026-04-21

Go Capital
Investor
Go Capital
GOCA3 · 2023 · VC

Key facts

HQFrance
SectorHealthcare

More from GOCA3

Other portfolio companies in the same fund.

Axomove
Axomove
Active
MedTechFrance· 2026
VirtualBrowser
VirtualBrowser
Active
CybersecurityFrance· 2026
Alkion Bioinnovations
Active
IndustrialsFrance· 2025
Delivrone
Active
IndustrialsFrance· 2025
Expliseat
Expliseat
Active
Aerospace & DefenceFrance· 2025
Sirius Neosight
Sirius Neosight
Active
HealthTechFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Phaxiam Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Phaxiam Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Phaxiam Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue